In:
International Journal of Research in Pharmaceutical Sciences, GP Innovations Pvt. Ltd., Vol. 11, No. SPL1 ( 2020-08-06), p. 369-375
Abstract:
The Coronavirus (COVID-19) caused by severe acute respiratory syndrome, coronavirus 2(SARS-CoV-2). The COVID-19 pandemic has had a catastrophic effect on global health. About 2% of confirmed cases of COVID-19 were among children aged 〈 18yrs old. Children, teens and young adults are at higher risk for severe complication and presentation with multisystem inflammatory disease. Management of children with COVID infection is not yet standardized. However, cancer children are at potential risk due to immunocompromised status and their management is unknown. The immunocompromised children are at risk of severe infection, and they have a high mortality rate. Here in this article, we are describing when to suspect COVID infection, how to manage newly diagnosed cancer children and existing patient including bone marrow transplantation and immunosuppression therapy and also blood transfusion policy during COVID pandemic time.
Type of Medium:
Online Resource
ISSN:
0975-7538
DOI:
10.26452/ijrps.v11iSPL1
DOI:
10.26452/ijrps.v11iSPL1.2728
Language:
Unknown
Publisher:
GP Innovations Pvt. Ltd.
Publication Date:
2020
